<DOC>
	<DOCNO>NCT02116946</DOCNO>
	<brief_summary>This randomize controlled clinical trial investigate effectiveness , safety tolerability platelet-rich plasma ( PRP ) injection treatment patellar tendinopathy adult 18-50 year age . Subjects randomly assign three parallel treatment group : 1 . Leukocyte-rich PRP injection + exercise 2 . Leukocyte-poor PRP injection + exercise 3 . Saline injection + exercise ( control ) Primary endpoint ( 1 ) number ( rate ) severity adverse event report patient study physician first 12 week initiation treatment , ( 2 ) patient-rated tolerability treatment ; ( 3 ) change function ( VISA score ) treatment success ( global improvement scale ) six month post-injection exercise protocol .</brief_summary>
	<brief_title>Plasma Injections Plus Exercise Patellar Tendinopathy</brief_title>
	<detailed_description />
	<mesh_term>Tendinopathy</mesh_term>
	<criteria>Male female ≥ 18 ≤ 50 year age Enrollment Visit Documentation clinical diagnosis patellar tendinopathy , gradeIIIB Blazina stage , confirm ultrasound Previously try exercise program least six week duration Fluent official language study site Written inform consent obtain subject Normal value screen laboratory panel ( CBC , PT , PTT , INR , serum creatine , ALT , ALP , AST , bilirubin , albumin ) For woman childbearing potential , positive pregnancy test enrollment visit Major surgery past three month Surgery symptomatic knee Bleeding disorder Systemic inflammatory disease Arthritis degenerative knee condition Recent fluoroquinolone use Subjects requirement use systemic steroid immunosuppressant Subjects know HIV positive Uncooperative patient , patient incapable following direction predictably unwilling return followup examination Presence condition abnormality opinion Investigator would compromise safety patient quality data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>